Correlation Between Blueprint Medicines and Incyte
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Incyte, you can compare the effects of market volatilities on Blueprint Medicines and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Incyte.
Diversification Opportunities for Blueprint Medicines and Incyte
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Blueprint and Incyte is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Incyte go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Incyte
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 4.04 times less return on investment than Incyte. In addition to that, Blueprint Medicines is 1.03 times more volatile than Incyte. It trades about 0.02 of its total potential returns per unit of risk. Incyte is currently generating about 0.08 per unit of volatility. If you would invest 6,564 in Incyte on August 28, 2024 and sell it today you would earn a total of 788.00 from holding Incyte or generate 12.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Incyte
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Incyte |
Blueprint Medicines and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Incyte
The main advantage of trading using opposite Blueprint Medicines and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |